| Literature DB >> 35538528 |
Hamza Sekkat1,2, Amine Souadka1,2, Lise Courtot3, Ali Rafik1,2, Laila Amrani1,2, Amine Benkabbou1,2, Pierre Peyrafort3, Urs Giger-Pabst3,4, Elias Karam3, Raouf Mohsine1,2, Anass M Majbar5,6, Mehdi Ouaissi3,4.
Abstract
INTRODUCTION: This study aimed to externally evaluate the accuracy of four predictive scores for conversion to open surgery after rectal laparoscopic resection. None of the four scores achieved external validation previously.Entities:
Keywords: Conversion; Laparoscopy; Predictive models; Rectal neoplasms
Mesh:
Year: 2022 PMID: 35538528 PMCID: PMC9092680 DOI: 10.1186/s12893-022-01617-9
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.102
Patients’ characteristics
| Age (SD) years | 65.95 (12.2) |
|---|---|
| Sex | |
| Male | 264(66%) |
| Female | 136(34%) |
| PS | |
| 0–1 | 387(96.75%) |
| > 1 | 13(3.25%) |
| ASA score | |
| 1–2 | 343(85.75%) |
| > 2 | 50(12.5%) |
| Missing | 7(1.75%) |
| BMI (Kg/m2) | |
| < 18 | 14(4.5%) |
| 18—28 | 283(70.75%) |
| > 28 | 97(24.25%) |
| Missing | 6 |
| History of surgery | |
| Yes | 20(5%) |
| No | 380(95%) |
| Tumor location | |
| Median (quartiles) cm | 7(4–11) |
| Low | 116(29%) |
| Medium | 124(31%) |
| Hight | 155(38.75%) |
| Missing | 5 |
| Neoadjuvant CRT | 283(70.75%) |
| pT Stage | |
| 0–3 | 377(94.25%) |
| 4 | 22(5.5%) |
| Missing | 1 |
| M stage | |
| M0 | 347(86.75%) |
| M1 | 52(13%) |
| CRM + | 25(6.25%) |
| DRM + | 25(6.25%) |
| Conversion rate | 21.75% |
PS performance status, ASA American Score of Anesthesiologists, CRT chemoradiotherapy, CRM circumferential resection margin, DRM distal resection margin
Fig. 1Comparison of area under the curve for all models
Fig. 2Observed versus predicted conversion rates for the four conversion scoring systems
Univariate and multivariate analysis of predictive factors for conversion
| Variable | Univariate analysis | p | Multivariate analysis | p |
|---|---|---|---|---|
| Sex | 0.361 | |||
| Male | 61/264 (23.3) | |||
| Female | 26/136 (19.1) | |||
| Age | 0.05 | 1.59 (0.86—2.92) | 0.14 | |
| < 60 | 18/117 (15.5) | |||
| > 60 | 69/283 (24.5) | |||
| PS status | 0.91 | |||
| 0–1 | 84/387 (21.8) | |||
| 2–3 | 3/13 (23.1) | |||
| ASA score | 0.423 | |||
| 1–2 | 72/343 (21.0) | |||
| 3–4 | 13/50 (27.1) | |||
| Tumor location | 0.73 | |||
| Low | 26/116 (22.4) | |||
| Mid | 24/124 (19.5) | |||
| High | 36/155 (23.4) | |||
| Neoadjuvant CRT | 0.28 | |||
| No | 20/108 (18.7) | |||
| Yes | 67/283 (23.8) | |||
| BMI | ||||
| < 28 | 50/299 (16.7) | |||
| > 28 | ||||
| Body surface | 1.79 (0.97—3.33) | 0.06 | ||
| < 1.8 | 24/173 (14) | |||
| > 1.8 | ||||
| Previous laparotomy | 0.84 | |||
| No | 83/380 (21.9) | |||
| Yes | 4/20 (21.1) | |||
| Senior surgeon | ||||
| No | ||||
| Yes | ||||
| Case number > 50 | 0.78 | |||
| No | 80/365 (22) | |||
| Yes | 7/35 (20) | |||
| Case number > 25 | 2.06 (0.94—4.52) | 0.07 | ||
| No | 78/319 (24.6) | |||
| Yes | ||||
| pT stage | ||||
| 0–3 | ||||
| 4 | ||||
| M stage | 0.401 | |||
| M0 | 78/347 (22.6) | |||
| M1 | 9/52 (17.3) | |||
| Tumor size | 0.553 | |||
| < 6 cm | 65/319 (20.5) | |||
| > 6 cm | 10/41 (24.4) |
Bold values indicate the variable with significant statistical significance